Del Global Technologies new president of its Medical Systems Group

TriMed Staff | | Health Imaging | Artificial Intelligence
Del Global Technologies Corp. recently announced that Christopher N. Japp has been appointed president of the company's Del Medical Systems Group subsidiary.

Japp is responsible for the global operations of the Company's Del Medical Imaging subsidiary and its 80 percent-owned Villa Sistemi Medicali subsidiary. He now reports directly to Del Global's President and CEO Walter F. Schneider.

Japp comes to Del Global from St. Jude Medical International, where he served as vice president, cardiac surgery since 2003. During this time he led efforts to increase international sales, broaden new business opportunities, and develop and implement sales incentive plans. Between 1990 and 2003 he held positions of increasing responsibility at GE Healthcare.

TriMed Staff

Related Content

Experts highlight 'significant concerns' with fluctuating accuracy of popular large language models
FDA clears AI screening tool for cardiac amyloidosis
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
Deep learning reconstruction cuts radiation and contrast dose by half in aortic CTA exams
New study highlights the need to include more challenging datasets in AI training

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.